Safety Pharmacology Society Northeast Regional Meeting, May 1, Cambridge, MA

Join CBSET and our partner Cilcare at the Safety Pharmacology Society Northeast Regional Meeting, May 1, from 9:00 AM to 4:00 PM, hosted by Takeda, 35 Landsdown Street, Cambridge, Massachusetts.

This year’s meeting theme is Emerging Innovative Approaches to Therapeutic Risk Mitigation in Safety Pharmacology and Beyond. We will be explore identifying and mitigating safety concerns with an expanding range of new technologies, including  macro molecule therapies, medical materials, and devices. CBSET will be exhibiting and speaking.
REGISTER HERE


CBSET Study Director, Donald Hodges PhD, MSc, DSP,  is a co-organizer and session co-chair for the meeting.

CBSET will be presenting on the topic of Neural and Cardiac Biomarker Applications for Preclinical Testing (Hayden Dillow, Pathology Technician)

Cilcare will be presenting on the topics of:

Ototoxic Treatments in Cochlear Cultures (Carolanne Coyat, PhD, Anatomy & Physiology Senior Scientist)

Please contact us to schedule a meeting at the Safety Pharmacology Society Regional Meeting.





    Intra-cochlear Delivery for Gene Therapy in Rodents (Sebastien Diot, R&D Project Manager, Anatomy & Physiology Scientist)


    HEAR THIS! Potential Therapeutics for COVID-19 Should Be Tested for Auditory Safety

    by Wahid Awad, PhD, Chief Business Officer, CILcare and Michael Naimark, Director of Business Development, CBSET, Inc.

    World Pharma Today, August 24, 2020


    wpt-coverAuditory Therapy, Ototoxicity, and GLP Compliance: Will the promising market for ear disorder treatments follow ophthalmology’s dramatic growth curve?

    by Michael Naimark, Director of Business Development, CBSET, Inc. and Marie-Pierre Pasdelou, PharmD, founder and the Chief Development Officer, CILcare

    Published in World Pharma Today, November 1, 2017